查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572981

生物醫學測試和分析服務市場：按技術、最終用戶、測試類型、樣本類型 - 2025-2030 年全球預測

Biomedical Testing & Analysis Services Market by Technology, End Users, Test Type, Sample Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物醫學測試和分析服務市值為31.7億美元，預計2024年將達到33.8億美元，複合年成長率為7.94%，到2030年將達到54.2億美元，預計將達到1000萬美元。

生物醫學測試和分析服務市場涵蓋廣泛的診斷和分析服務，旨在分析生物樣本以進行疾病診斷、治療監測和高級研究。它透過提供重要資料來指導臨床決策並確保治療方法的安全性和有效性，在醫療保健中發揮關鍵作用。主要應用包括病理學、毒理學、基因檢測和臨床檢測，最終用戶包括醫院、研究機構、製藥公司和生物技術公司。市場成長主要受到慢性病盛行率上升、診斷中自動化和人工智慧等技術進步以及對個人化醫療日益重視的影響。此外，COVID-19 大流行加速了對快速、準確檢測解決方案的需求，為市場擴張提供了利潤豐厚的機會。值得注意的機會在於開拓可攜式診斷解決方案、擴展到新興市場以及與高科技公司合作創新人工智慧主導的分析工具。

主要市場統計
基準年[2023] 31.7億美元
預測年份 [2024] 33.8億美元
預測年份 [2030] 54.2億美元
複合年成長率（%） 7.94%

然而，仍存在一些限制和挑戰，包括嚴格的法律規範、與先進診斷技術相關的高成本以及資料隱私和安全問題。此外，缺乏熟練的專業人員以及將新技術融入現有醫療基礎設施的複雜性也可能阻礙市場成長。非侵入性檢測、即時資料分析和生物銀行等領域的創新提供了巨大的業務成長潛力。在降低成本的同時提高測試速度和準確性的研究至關重要。適應不斷變化的監管要求並專注於策略夥伴關係關係也可能支持市場成功。鑑於該市場的競爭性質，企業必須利用數位技術的進步來改善服務交付並最大限度地提高客戶滿意度。透過預測市場趨勢並積極應對現有挑戰，公司可以在這個充滿活力且快速發展的細分市場中獲得優勢。

市場動態：揭示快速發展的生物醫學測試和分析服務市場的關鍵市場洞察

供需的動態交互作用正在改變生物醫學測試和分析服務市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對早期疾病檢測和個人化醫療的需求不斷成長推動生物醫學檢測市場
    • 技術和自動化的進步提高了生物醫學測試服務的準確性和效率
    • 慢性病盛行率上升和人口老化促進生物醫學檢測服務的成長
    • 在藥物開發和疾病治療中擴大採用基因組學和蛋白​​質組學研究來推動市場
  • 市場限制因素
    • 難以確保生物醫學測試和分析服務嚴格的監管要求和合規標準
    • 來自生物醫學研究設施內部測試能力和先進自動化系統的激烈競爭
  • 市場機會
    • 透過生物技術公司和診斷實驗室之間的合作促進創新
    • 對非侵入性檢測方法的更多關注增加了醫療篩檢的頻率和可近性
    • 支持生物醫學測試和分析進步的監管環境和資金籌措機會
  • 市場問題
    • 與生物醫學測試和分析服務相關的資料隱私和安全問題
    • 缺乏熟練的專業人員，包括實驗室技術人員、生物資訊學專家和臨床研究人員

波特五力：駕馭生物醫學測試與分析服務市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物醫學測試和分析服務市場的外部影響

外部宏觀環境因素在塑造生物醫學測試和分析服務市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析了解生物醫學測試和分析服務市場的競爭格局

對生物醫學測試和分析服務市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物醫學測試和分析服務市場供應商的績效評估

FPNV 定位矩陣是評估生物醫學測試和分析服務市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，規劃生物醫學測試和分析服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物醫學測試和分析服務市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對早期疾病檢測和個人化治療的需求不斷成長推動生物醫學檢測市場
      • 技術和自動化的進步提高了生物醫學測試服務的準確性和效率
      • 慢性病的增加和人口老化正在促進生物醫學檢測服務的成長
      • 在藥物開發和疾病治療中擴大採用基因組學和蛋白​​質組學研究推動了市場
    • 抑制因素
      • 難以確保生物醫學測試和分析服務嚴格的監管要求和合規標準
      • 生物醫學研究設施內部測試能力與先進自動化系統之間的激烈競爭
    • 機會
      • 生技公司和診斷實驗室之間的合作加速創新
      • 促進更頻繁、更方便的醫療診斷，並專注於非侵入性檢測方法
      • 支持生物醫學測試和分析進步的監管環境和資金籌措機會
    • 任務
      • 與生物醫學測試和分析服務相關的資料隱私和安全問題
      • 實驗室技術人員、生物資訊專家、臨床研究人員等熟練專業人員短缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章生物醫學測試與分析服務市場：依技術分類

  • 介紹
  • 基於細胞的測試
    • 細胞活力測定
    • 高內涵篩檢
    • 活細胞成像
  • 臨床化學
  • 血液學
  • 免疫檢測
    • ELISA
    • 免疫檢測
    • 西方墨點法
  • 質譜分析
    • 代謝體學
    • 蛋白質體學
  • 微生物檢測
  • 分子診斷
    • DNA序列分析
    • 恒溫核酸增幅
    • 微陣列
    • PCR

第7章生物醫學測試和分析服務市場：按最終用戶分類

  • 介紹
  • 生物技術和製藥公司
  • 診斷實驗室
  • 醫院/診所
  • 研究所和學術中心

第8章生物醫學測試和分析服務市場：按測試類型

  • 介紹
  • 診斷
  • 初步檢查
  • 預後
  • 篩檢
  • 治療監測

第9章生物醫學測試和分析服務市場：按樣本類型

  • 介紹
  • 血
  • 腦脊髓液
  • 唾液
  • 凳子
  • 組織切片檢查
  • 尿

第10章美洲生物醫學測試與分析服務市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太生物醫學測試與分析服務市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲生物醫學測試和分析服務市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-2B5802CFE404

The Biomedical Testing & Analysis Services Market was valued at USD 3.17 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 7.94%, to USD 5.42 billion by 2030.

The Biomedical Testing & Analysis Services market encompasses a broad range of diagnostic and analytical services aimed at analyzing biological samples for disease diagnosis, therapeutic monitoring, and advanced research purposes. It plays a critical role in healthcare by providing essential data that guides clinical decision-making and ensures the safety and efficacy of treatment regimens. Key applications include pathology, toxicology, genetic testing, and clinical trials, with end-users ranging from hospitals, research institutes, and pharmaceutical companies to biotechnology firms. The market's growth is primarily influenced by the rising prevalence of chronic diseases, technological advancements such as automation and artificial intelligence in diagnostics, and the increasing emphasis on personalized medicine. Furthermore, the COVID-19 pandemic has accelerated the demand for rapid and accurate testing solutions, providing lucrative opportunities for market expansion. Noteworthy opportunities lie in the development of portable diagnostic solutions, expansion into emerging markets, and collaboration with tech companies to innovate AI-driven analytical tools.

KEY MARKET STATISTICS
Base Year [2023] USD 3.17 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.42 billion
CAGR (%) 7.94%

However, some limitations and challenges persist, such as stringent regulatory frameworks, high costs associated with advanced diagnostic technologies, and issues related to data privacy and security. Additionally, market growth could be hindered by a shortage of skilled professionals and the complexities of integrating new technologies within existing healthcare infrastructures. Innovating in areas like non-invasive testing methods, real-time data analytics, and biobanking could offer substantial business growth potential. Research into enhancing test speed and accuracy, while reducing costs, will be essential. Adapting to the evolving landscape of regulatory requirements and focusing on strategic partnerships can also drive market success. Considering the competitive nature of this market, companies should leverage advancements in digital technology to improve service delivery and maximize customer satisfaction. By anticipating market trends and addressing existing challenges proactively, businesses can stay ahead in this dynamic and rapidly evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomedical Testing & Analysis Services Market

The Biomedical Testing & Analysis Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
    • Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
    • Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
    • Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
  • Market Restraints
    • Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
    • Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
  • Market Opportunities
    • Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
    • Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
    • Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
  • Market Challenges
    • Data privacy and security concerns associated with biomedical testing & analysis services
    • Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher

Porter's Five Forces: A Strategic Tool for Navigating the Biomedical Testing & Analysis Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomedical Testing & Analysis Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomedical Testing & Analysis Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomedical Testing & Analysis Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomedical Testing & Analysis Services Market

A detailed market share analysis in the Biomedical Testing & Analysis Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomedical Testing & Analysis Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomedical Testing & Analysis Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomedical Testing & Analysis Services Market

A strategic analysis of the Biomedical Testing & Analysis Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomedical Testing & Analysis Services Market, highlighting leading vendors and their innovative profiles. These include BioIVT, BioReliance Corporation, Charles River Laboratories International, Inc., Covance Inc., Envigo, Eurofins Scientific, Frontage Laboratories, Inc., ICON Central Laboratories, ICON plc, Inotiv, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Product Development, LLC, PPD, Inc., PRA Health Sciences, Inc., SGS SA, Syneos Health, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Biomedical Testing & Analysis Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Cell-Based Tests, Clinical Chemistry, Hematology, Immunoassays, Mass Spectrometry, Microbiological Testing, and Molecular Diagnostics. The Cell-Based Tests is further studied across Cell Viability Assays, High Content Screening, and Live Cell Imaging. The Immunoassays is further studied across ELISA, Radioimmunoassay, and Western Blot. The Mass Spectrometry is further studied across Metabolomics and Proteomics. The Molecular Diagnostics is further studied across DNA Sequencing, Isothermal Nucleic Acid Amplification, Microarray, and PCR.
  • Based on End Users, market is studied across Biotechnology & Pharmaceutical Companies, Diagnostic Laboratories, Hospitals & Clinics, and Research Institutions & Academic Centers.
  • Based on Test Type, market is studied across Diagnostic, Preliminary Testing, Prognostic, Screening, and Therapeutic Monitoring.
  • Based on Sample Type, market is studied across Blood, Cerebrospinal Fluid, Saliva, Stool, Tissue Biopsy, and Urine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for early disease detection and personalized medical treatment driving the biomedical testing market
      • 5.1.1.2. Advancements in technology and automation enhancing the accuracy and efficiency of biomedical testing services
      • 5.1.1.3. Rising prevalence of chronic diseases and aging population contributing to the growth of biomedical testing services
      • 5.1.1.4. Growing adoption of genomics and proteomics studies in drug development and disease treatment boosting the market
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties in ensuring stringent regulatory requirements and compliance standards for biomedical testing and analysis services
      • 5.1.2.2. Intense competition from in-house testing capabilities and advanced automated systems in biomedical research facilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborative partnerships between biotech firms and diagnostic labs accelerating innovation
      • 5.1.3.2. Increased focus on non-invasive testing methods promoting more frequent and accessible healthcare screenings
      • 5.1.3.3. Regulatory landscape and funding opportunities supporting advances in biomedical testing and analysis
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy and security concerns associated with biomedical testing & analysis services
      • 5.1.4.2. Lack of skilled professionals including lab technicians, bioinformatics experts, and clinical researcher
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biomedical Testing & Analysis Services Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell-Based Tests
    • 6.2.1. Cell Viability Assays
    • 6.2.2. High Content Screening
    • 6.2.3. Live Cell Imaging
  • 6.3. Clinical Chemistry
  • 6.4. Hematology
  • 6.5. Immunoassays
    • 6.5.1. ELISA
    • 6.5.2. Radioimmunoassay
    • 6.5.3. Western Blot
  • 6.6. Mass Spectrometry
    • 6.6.1. Metabolomics
    • 6.6.2. Proteomics
  • 6.7. Microbiological Testing
  • 6.8. Molecular Diagnostics
    • 6.8.1. DNA Sequencing
    • 6.8.2. Isothermal Nucleic Acid Amplification
    • 6.8.3. Microarray
    • 6.8.4. PCR

7. Biomedical Testing & Analysis Services Market, by End Users

  • 7.1. Introduction
  • 7.2. Biotechnology & Pharmaceutical Companies
  • 7.3. Diagnostic Laboratories
  • 7.4. Hospitals & Clinics
  • 7.5. Research Institutions & Academic Centers

8. Biomedical Testing & Analysis Services Market, by Test Type

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Preliminary Testing
  • 8.4. Prognostic
  • 8.5. Screening
  • 8.6. Therapeutic Monitoring

9. Biomedical Testing & Analysis Services Market, by Sample Type

  • 9.1. Introduction
  • 9.2. Blood
  • 9.3. Cerebrospinal Fluid
  • 9.4. Saliva
  • 9.5. Stool
  • 9.6. Tissue Biopsy
  • 9.7. Urine

10. Americas Biomedical Testing & Analysis Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomedical Testing & Analysis Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomedical Testing & Analysis Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BioIVT
  • 2. BioReliance Corporation
  • 3. Charles River Laboratories International, Inc.
  • 4. Covance Inc.
  • 5. Envigo
  • 6. Eurofins Scientific
  • 7. Frontage Laboratories, Inc.
  • 8. ICON Central Laboratories
  • 9. ICON plc
  • 10. Inotiv, Inc.
  • 11. IQVIA Holdings Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. Medpace Holdings, Inc.
  • 14. Parexel International Corporation
  • 15. Pharmaceutical Product Development, LLC
  • 16. PPD, Inc.
  • 17. PRA Health Sciences, Inc.
  • 18. SGS SA
  • 19. Syneos Health
  • 20. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL VIABILITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY LIVE CELL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS & ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PRELIMINARY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STOOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. FRANCE BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. GERMANY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. ISRAEL BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ITALY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NETHERLANDS BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY CELL-BASED TESTS, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. NIGERIA BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY BIOMEDICAL TESTING & ANALYSIS SERVICES MARK